Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Fungal membrane and intracellular biosynthetic pathways" refers to the collective molecular structures and metabolic processes in pathogenic fungi that are targeted by the secondary metabolites of the biocontrol fungus Clonostachys rosea (Sun et al., 2020, "Secondary metabolites from the mycoparasitic fungus Clonostachys rosea"). These targets primarily include the fungal cell membrane, which is disrupted by peptaibols—short, non-ribosomally synthesized peptides—that insert into the lipid bilayer to form ion channels or pores, leading to the leakage of essential ions and eventual cell death (Nygren et al., 2018, "The mycoparasitic fungus Clonostachys rosea responds to B. cinerea"). Additionally, C. rosea produces various polyketides and non-ribosomal peptides that interfere with intracellular biosynthetic pathways, such as those responsible for ergosterol synthesis and cell wall maintenance (Karlsson et al., 2015, "Insights into the Mycoparasitic Lifestyle of Clonostachys rosea"). By disrupting these essential systems, C. rosea effectively suppresses the growth and virulence of agricultural pathogens like Botrytis cinerea and Fusarium species. This multi-faceted mechanism of action makes these pathways critical focal points for understanding mycoparasitism and developing natural fungicidal agents for sustainable agriculture. However, because this entry describes a broad category of biological processes rather than a single protein or receptor, it is classified as a descriptive mechanism rather than a specific therapeutic target.
Disruption of fungal membrane integrity through pore formation and inhibition of essential biosynthetic enzymes involved in ergosterol and cell wall synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal membrane and intracellular biosynthetic pathways.